Suchergebnisse - "O3J8G9O825"

PubPharm (4.581)

101

Real-world Effectiveness of Molnupiravir and Nirmatrelvir/Ritonavir as Treatments for COVID-19 in Patients at High Risk

enthalten in: The Journal of infectious diseases | 2023

von Paraskevis, D. | Gkova, M. | Mellou, K. | +16

102

Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19 : Emulation of a randomized target trial

enthalten in: Journal of medical virology | 2023

von Zhou, Y. | Liu, Y. | Jiang, L. | +15

103

A model-based pharmacokinetic assessment of drug-drug interaction between tacrolimus and nirmatrelvir/ritonavir in a kidney transplant patient with COVID-19

enthalten in: Drug metabolism and pharmacokinetics | 2023

von Tomida, T. | Itohara, K. | Yamamoto, K. | +8

104

Budget impact of oral nirmatrelvir/ritonavir in adults at high risk for progression to severe COVID-19 in the United States

enthalten in: Journal of managed care & specialty pharmacy | 2023

von Sandin, R. | Veenstra, D. | Vankelegom, M. | +8

105

Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis : target trial emulation

enthalten in: Nature communications | 2023

von Wong, C. | Lau, J. | Au, I. | +5

106

Potential drug-drug interactions among U.S. adults treated with nirmatrelvir/ritonavir : A cross-sectional study of the National Covid Cohort Collaborative (N3C)

enthalten in: Pharmacotherapy | 2023

von Xiao, X. | Mehta, H. | Curran, J. | +103

107

Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19

enthalten in: International journal of antimicrobial agents | 2023

von Wu, J. | Liu, M. | Liu, T. | +5

108

Dosing recommendation of nirmatrelvir/ritonavir using an integrated population pharmacokinetic analysis

enthalten in: CPT: pharmacometrics & systems pharmacology | 2023

von Chan, P. | Singh, R. | Cox, D. | +3

109

Optimizing COVID-19 treatment in immunocompromised patients : early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab

enthalten in: Virology journal | 2023

von Gentile, I. | Foggia, M. | Silvitelli, M. | +3

110

Dual combined antiviral treatment with remdesivir and nirmatrelvir/ritonavir in patients with impaired humoral immunity and persistent SARS-CoV-2 infection

enthalten in: Hematological oncology | 2023

von Pasquini, Z. | Toschi, A. | Casadei, B. | +14